@article{00035163de9540689fc2adf900eef7bd,
title = "Denosumab: a novel antiresorptive drug for osteoporosis",
abstract = "Denosumab is a novel antiresorptive drug that has been approved for use as a first-line drug for primary and secondary prevention of osteoporotic fractures. The authors discuss the mechanism of action of denosumab, review the evidence for its efficacy and safety in patients with osteoporosis, and offer recommendations for its use in clinical practice.",
keywords = "Absorptiometry, Photon, Aged, Antibodies, Monoclonal, Humanized, Bone Density, Bone Density Conservation Agents, Denosumab, Female, Humans, Lumbar Vertebrae, Osteoporosis, Osteoporotic Fractures, RANK Ligand, Spinal Fractures, Thoracic Vertebrae",
author = "Ernest Suresh and Bo Abrahamsen",
note = "Copyright {\textcopyright} 2015 Cleveland Clinic.",
year = "2015",
month = feb,
doi = "10.3949/ccjm.82a.13173",
language = "English",
volume = "82",
pages = "105--14",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",
number = "2",
}